Bacteria residing in the gut microbiome have been identified as significant contributors to the severe side effects experienced during allogeneic haematopoietic cell transplantation, particularly when using genetically dissimilar blood stem cells.
Research shows that an integrated approach targeting gut bacteria with viral-derived enzymes may offer a promising strategy for alleviating the complications associated with allogeneic blood stem cell treatments, potentially improving patient outcomes.
#gut-microbiome #allogeneic-transplantation #blood-stem-cells #viral-enzymes #treatment-complications
Collection
[
|
...
]